$GNPX
Genprex Inc

2018 Q3 Form 10-Q Financial Statement

#000156459018029612 Filed on November 14, 2018

View on sec.gov

Income Statement

Concept 2018 Q3 2017 Q4 2017 Q3
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.710M $600.0K $660.0K
YoY Change 159.09% -31.03% 4.76%
% of Gross Profit
Research & Development $489.7K $60.00K $55.52K
YoY Change 782.05% -53.85% -38.31%
% of Gross Profit
Depreciation & Amortization $1.713K $0.00 $808.00
YoY Change 112.0%
% of Gross Profit
Operating Expenses $489.7K $660.0K $55.52K
YoY Change 782.05% -34.0% -92.29%
Operating Profit -$2.197M -$715.1K
YoY Change 207.26%
Interest Expense $0.00 $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$2.190M -$670.0K -$720.0K
YoY Change 204.17% -33.0% 0.0%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$2.186M -$670.0K -$715.1K
YoY Change 205.7% -33.0% -0.68%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$149.2K -$51.38K -$44.47K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q3 2017 Q4 2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.31M $160.0K $370.0K
YoY Change 2686.49% -90.0%
Cash & Equivalents $10.31M $161.3K $373.9K
Short-Term Investments
Other Short-Term Assets $370.0K $20.00K $30.00K
YoY Change 1133.33% -50.0%
Inventory
Prepaid Expenses
Receivables $10.00K $10.00K
Other Receivables $0.00 $0.00
Total Short-Term Assets $10.69M $193.6K $400.0K
YoY Change 2572.32% -88.19%
LONG-TERM ASSETS
Property, Plant & Equipment $15.99K $7.804K $10.00K
YoY Change 59.9% 51.33%
Goodwill
YoY Change
Intangibles $298.6K
YoY Change 23.87%
Long-Term Investments
YoY Change
Other Assets $20.00K $1.058M $560.0K
YoY Change -96.43% 296.99%
Total Long-Term Assets $360.7K $1.066M $870.0K
YoY Change -58.54% 292.33%
TOTAL ASSETS
Total Short-Term Assets $10.69M $193.6K $400.0K
Total Long-Term Assets $360.7K $1.066M $870.0K
Total Assets $11.05M $1.260M $1.270M
YoY Change 770.08% -34.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $570.0K $630.0K $360.0K
YoY Change 58.33% 117.24%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $200.0K $30.00K
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $570.0K $831.0K $400.0K
YoY Change 42.5% 190.89%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $570.0K $831.0K $400.0K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $570.0K $830.0K $400.0K
YoY Change 42.5% 186.21%
SHAREHOLDERS EQUITY
Retained Earnings -$17.45M
YoY Change 23.44%
Common Stock $11.72K
YoY Change 3.14%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $10.48M $428.6K $870.0K
YoY Change
Total Liabilities & Shareholders Equity $11.05M $1.260M $1.270M
YoY Change 770.08% -34.07%

Cashflow Statement

Concept 2018 Q3 2017 Q4 2017 Q3
OPERATING ACTIVITIES
Net Income -$2.186M -$670.0K -$715.1K
YoY Change 205.7% -33.0% -0.68%
Depreciation, Depletion And Amortization $1.713K $0.00 $808.00
YoY Change 112.0%
Cash From Operating Activities -$1.470M -$210.0K -$640.0K
YoY Change 129.69% -75.29% 326.67%
INVESTING ACTIVITIES
Capital Expenditures -$10.00K $0.00 -$20.00K
YoY Change -50.0% -100.0% -71.43%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$10.00K $0.00 -$20.00K
YoY Change -50.0% -100.0% -71.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -220.0K 0.000 560.0K
YoY Change -139.29% -100.0% -52.14%
NET CHANGE
Cash From Operating Activities -1.470M -210.0K -640.0K
Cash From Investing Activities -10.00K 0.000 -20.00K
Cash From Financing Activities -220.0K 0.000 560.0K
Net Change In Cash -1.700M -210.0K -100.0K
YoY Change 1600.0% -133.33% -110.53%
FREE CASH FLOW
Cash From Operating Activities -$1.470M -$210.0K -$640.0K
Capital Expenditures -$10.00K $0.00 -$20.00K
Free Cash Flow -$1.460M -$210.0K -$620.0K
YoY Change 135.48% -74.7% 675.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
9157
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
CY2018Q3 us-gaap Cash
Cash
10309704
CY2018Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
370409
CY2018Q3 us-gaap Assets Current
AssetsCurrent
10689270
CY2018Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15990
CY2018Q3 us-gaap Deferred Offering Costs
DeferredOfferingCosts
0
CY2018Q3 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
18085
CY2017Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
0
CY2017Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
298569
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1058160
CY2017Q4 us-gaap Assets
Assets
1259538
CY2017Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
629074
CY2018Q3 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
0
CY2017Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
201890
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
830964
CY2017Q4 gnpx Investment Unit
InvestmentUnit
0
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
11721
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
17869205
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17452352
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
428574
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1259538
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11721584
us-gaap Revenues
Revenues
0
CY2017Q3 us-gaap Depreciation
Depreciation
808
us-gaap Depreciation
Depreciation
3831
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
489689
CY2018Q3 us-gaap Depreciation
Depreciation
1713
CY2018Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1705876
CY2018Q3 us-gaap Costs And Expenses
CostsAndExpenses
2197278
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2197278
CY2018Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
11192
CY2018Q3 us-gaap Interest Expense
InterestExpense
0
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-2186086
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.15
CY2018Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
14675631
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2416557
CY2017Q3 us-gaap Costs And Expenses
CostsAndExpenses
715122
us-gaap Costs And Expenses
CostsAndExpenses
8919997
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11721584
CY2017Q3 us-gaap Revenues
Revenues
0
us-gaap Revenues
Revenues
0
us-gaap Depreciation
Depreciation
2213
CY2017Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
55517
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
654279
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
228860
CY2017Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
658797
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8261887
us-gaap Costs And Expenses
CostsAndExpenses
2647630
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-715122
us-gaap Operating Income Loss
OperatingIncomeLoss
-8919997
us-gaap Operating Income Loss
OperatingIncomeLoss
-2647630
CY2017Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
24
us-gaap Investment Income Interest
InvestmentIncomeInterest
16682
us-gaap Investment Income Interest
InvestmentIncomeInterest
55
CY2017Q3 us-gaap Interest Expense
InterestExpense
0
us-gaap Interest Expense
InterestExpense
37982
us-gaap Interest Expense
InterestExpense
0
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-715098
us-gaap Net Income Loss
NetIncomeLoss
-8941297
us-gaap Net Income Loss
NetIncomeLoss
-2647575
CY2017Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.67
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.23
CY2017Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
11634307
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
13323557
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
11504974
us-gaap Share Based Compensation
ShareBasedCompensation
3822076
us-gaap Share Based Compensation
ShareBasedCompensation
1100328
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
313
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-8182
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
346930
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1540
us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
-18085
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-759591
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
534303
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-63681
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
109588
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4784808
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1960027
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12017
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5998
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
27413
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
56343
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-39430
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-62341
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
201890
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
15174581
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
794019
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
14972691
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
794019
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
10148453
CY2014Q1 gnpx Conversion Of Stock Shares Issued And Forward Stock Split
ConversionOfStockSharesIssuedAndForwardStockSplit
1235219
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1228349
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
161251
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1602295
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10309704
CY2017Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
373946
us-gaap Interest Paid Net
InterestPaidNet
10645
us-gaap Income Taxes Paid
IncomeTaxesPaid
0
us-gaap Income Taxes Paid
IncomeTaxesPaid
0
CY2013Q4 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
2500000
CY2014Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.001
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Use of Estimates</font></p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of our condensed financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. </p></div>
us-gaap Debt Instrument Description
DebtInstrumentDescription
If no event of default occurs prior to August 13, 2020, the Promissory Note and all related interest will be cancelled.
gnpx Warrant Right To Purchase Percentage
WarrantRightToPurchasePercentage
0.80
us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
6.6841954
CY2018Q3 gnpx Capital Stock Shares Authorized
CapitalStockSharesAuthorized
210000000
CY2018Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2018Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2017Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2018Q3 us-gaap Cash Uninsured Amount
CashUninsuredAmount
10059704
CY2017Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
0
CY2018Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2017Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2017 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2018Q3 gnpx Number Of Patents
NumberOfPatents
30
gnpx Number Of Pending Patents
NumberOfPendingPatents
2
CY2018Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
4500000
CY2018Q3 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.08
us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2020-08-13
gnpx Warrant Discount Rate
WarrantDiscountRate
0.20
CY2018Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.001
CY2018Q2 gnpx Warrant To Purchase Shares Of Common Stock
WarrantToPurchaseSharesOfCommonStock
38400
us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
33420
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
176650
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
38422
CY2017 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
207206
CY2017 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
1095230
CY2017Q4 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
150211
CY2018Q2 gnpx Non Voting Common Stock Conversion Ratio
NonVotingCommonStockConversionRatio
1
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2018Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2628749
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3579773
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
127593
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y5M9D
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y4M2D
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2628749
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1078617
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.31
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2017Q4 gnpx Percentage Applied On Outstanding Shares For Warrant To Purchase Shares Of Common Stock
PercentageAppliedOnOutstandingSharesForWarrantToPurchaseSharesOfCommonStock
0.03
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.34
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.00
CY2017Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
8000000

Files In Submission

Name View Source Status
Financial_Report.xlsx Edgar Link pending
0001564590-18-029612-index-headers.html Edgar Link pending
0001564590-18-029612-index.html Edgar Link pending
0001564590-18-029612.txt Edgar Link pending
0001564590-18-029612-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
gnpx-10q_20180930.htm Edgar Link pending
gnpx-20180930.xml Edgar Link completed
gnpx-20180930.xsd Edgar Link pending
gnpx-20180930_cal.xml Edgar Link unprocessable
gnpx-20180930_def.xml Edgar Link unprocessable
gnpx-20180930_lab.xml Edgar Link unprocessable
gnpx-20180930_pre.xml Edgar Link unprocessable
gnpx-ex311_8.htm Edgar Link pending
gnpx-ex312_7.htm Edgar Link pending
gnpx-ex321_9.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending